Similarly, in a longitudinal study of 37 cognitively normal individuals and 65 patients with Alzheimer’s disease within the memory-clinic-based Amsterdam Dementia Cohort, baseline CSF neurogranin levels in patients with the disease were significantly higher than in cognitively normal participants [263]. Here, NRGN is linked to Alzheimer disease.